AR018472A1 - Compuesto, composicion y metodo para el tratamiento de la perdida de cabello - Google Patents
Compuesto, composicion y metodo para el tratamiento de la perdida de cabelloInfo
- Publication number
- AR018472A1 AR018472A1 ARP000100917A ARP000100917A AR018472A1 AR 018472 A1 AR018472 A1 AR 018472A1 AR P000100917 A ARP000100917 A AR P000100917A AR P000100917 A ARP000100917 A AR P000100917A AR 018472 A1 AR018472 A1 AR 018472A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- heteroalkynyl
- heteroalkenyl
- heteroalkyl
- alkynyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
- C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
- C07C217/90—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to a carbon atom of a six-membered aromatic ring, e.g. amino-diphenylethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/25—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/75—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Compuestos y composiciones particularmente utiles para tratar la pérdida del cabello en mamíferos, incluyendo detener y/o revertir y estimularel crecimiento de éste. Los compuestos tienen una estructura bifenílica (I) y, preferiblemente, no afectan al corazon, en donde: R1, R2, R5, R7 y R10 son cadauno de manera independiente, seleccionados entre hidrogeno, halogeno, alquilo, alquenilo, alquinilo, heteroalquilo, heteroalquenilo y heteroalquinilo;R4 es seleccionado entre el grupo consistente en halogeno, alquilo, alquenilo, alquinilo, cicloalquilo, cicloalquenilo, arilo, arilalquilo, heteroalquilo,heteroalquenilo, heteroalquinilo, heterocicloalquilo, heterocicloalquenilo, heteroarilo, heteroarilalquilo, y heteroarilalquenilo; con lacondicionde que cuando R2 es hidrogeno, Y es -CH2CHK1, X es seleccionado entre -NZ- y -NH- y R12 es alquilo C1-4, en donde K1 es seleccionada entrehidrogeno y alquilo C1-4 y Z es alquilo C1-4, entonces R4 no sea arilalquilo; R8 y R9 son cada uno de manera independiente, seleccionados entre hidrogeno,halogeno, alquilo, alquenilo, alquinilo, cicloalquilo, cicloalquenilo, arilo, arilalquilo, heteroalquilo, heteroalquenilo, heteroalquinilo, heterocicloalquilo,heterocicloalquenilo, heteroarilo, heteroarilalquilo y heteroarilalquenilo; con la condicion que por lo menos uno, entre R8 y R9, no sea hidrogeno; R3 esseleccionado entre hidrogeno, alquilo, alquenilo, alquinilo, cicloalquilo, cicloalquenilo, arilo, arilalquilo, heteroalquilo, heteroalquenilo, heteroalquinilo,heterocicloalquilo, heterocicloalquenilo, heteroarilo, heteroarilalquilo y heteroarilalquenilo; Y es seleccionado entre un enlace, alquilo, alquenilo,alquinilo, heteroalquilo, heteroalquenilo y heteroalquinilo; X es seleccionado entre -NZ-, -NH- y -O-; R11 es seleccionado entre un enlace y -C(O)-; con lacondicion que cuando Y es un enlace y X es -O-, luego R11 será -C(O)-; y cuando Y es alquilo y X es -O- entonces R11 no será -C(O)-; R12 es seleccionado entrealquilo, alquenilo, alquinilo, heteroalquilo, heteroalquenilo, heteroalquinilo, cicloalquilo, cicloalquenilo, heterocicloalquilo, heterocicloalquenilo, arilo,
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13695899P | 1999-06-01 | 1999-06-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR018472A1 true AR018472A1 (es) | 2001-11-14 |
Family
ID=22475200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000100917A AR018472A1 (es) | 1999-06-01 | 2000-03-01 | Compuesto, composicion y metodo para el tratamiento de la perdida de cabello |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1183074A1 (es) |
JP (1) | JP2003500459A (es) |
AR (1) | AR018472A1 (es) |
AU (1) | AU3507600A (es) |
CA (1) | CA2375822A1 (es) |
MX (1) | MXPA01012491A (es) |
WO (1) | WO2000072920A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6664291B2 (en) | 2000-03-31 | 2003-12-16 | Pfizer, Inc. | Malonamic acids and derivatives thereof as thyroid receptor ligands |
PT1262177E (pt) * | 2001-05-31 | 2006-12-29 | Pfizer Prod Inc | Utilização medicinal de compostos tiromimético para tratamento da queda de cabelo e composições |
US7169564B1 (en) | 2001-06-26 | 2007-01-30 | Anaderm Research Corporation | FKBP51/52 and CyP40-mediated mammalian hair growth |
DE10131462A1 (de) * | 2001-06-29 | 2003-01-09 | Bayer Ag | Phenol-Derivate |
ES2253495T3 (es) | 2001-09-26 | 2006-06-01 | Pfizer Products Inc. | Acidos indol carboxilicos como ligandos de receptores tiroideos. |
ES2733353T3 (es) | 2007-11-09 | 2019-11-28 | Basf As | Compuestos lípidos para uso en productos cosméticos, como suplemento alimenticio o como un medicamento |
EP2147910A1 (en) | 2008-07-15 | 2010-01-27 | Pronova BioPharma Norge AS | Novel lipid compounds |
CA2760877C (en) | 2009-05-08 | 2020-09-08 | Pronova Biopharma Norge As | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas |
ES2618604T3 (es) | 2010-11-05 | 2017-06-21 | Pronova Biopharma Norge As | Métodos de tratamiento usando compuestos lipídicos |
DK2695611T3 (en) | 2012-08-06 | 2015-01-05 | Wolff August Gmbh & Co Kg Arzneimittel Dr | Eprotirome for use in the prevention and / or treatment of hair disorders and their compositions |
WO2014132134A1 (en) | 2013-02-28 | 2014-09-04 | Pronova Biopharma Norge As | A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same |
AU2016256552B2 (en) | 2015-04-28 | 2021-04-01 | Pronova Biopharma Norge As | Use of structurally enhanced fatty acids containing sulphur for preventing and/or treating non-alcoholic steatohepatitis |
KR20200096791A (ko) | 2017-12-06 | 2020-08-13 | 바스프 에이에스 | 비알콜성 지방간염 치료용 지방산 유도체 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE159515T1 (de) * | 1992-07-21 | 1997-11-15 | Ciba Geigy Ag | Oxamidsäure-derivate als hypocholesterämische mittel |
WO1996025943A1 (en) * | 1995-02-23 | 1996-08-29 | Life Medical Sciences, Inc. | Compositions and methods for enhancing the growth of hair and restoring hair color |
-
2000
- 2000-03-01 WO PCT/US2000/005251 patent/WO2000072920A1/en not_active Application Discontinuation
- 2000-03-01 MX MXPA01012491A patent/MXPA01012491A/es unknown
- 2000-03-01 EP EP00913676A patent/EP1183074A1/en not_active Withdrawn
- 2000-03-01 AU AU35076/00A patent/AU3507600A/en not_active Abandoned
- 2000-03-01 AR ARP000100917A patent/AR018472A1/es not_active Application Discontinuation
- 2000-03-01 CA CA002375822A patent/CA2375822A1/en not_active Abandoned
- 2000-03-01 JP JP2000621024A patent/JP2003500459A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2003500459A (ja) | 2003-01-07 |
WO2000072920A1 (en) | 2000-12-07 |
AU3507600A (en) | 2000-12-18 |
MXPA01012491A (es) | 2002-07-02 |
EP1183074A1 (en) | 2002-03-06 |
CA2375822A1 (en) | 2000-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR018472A1 (es) | Compuesto, composicion y metodo para el tratamiento de la perdida de cabello | |
PA8546301A1 (es) | Resolucion de sal quiral | |
DE50009643D1 (de) | Tensidzusammensetzung enthaltend geminitenside und co-amphiphile, ihre herstellung und ihre verwendung | |
AR008384A1 (es) | Composicion topica para el tratamiento de condiciones de la piel, uso del compuesto para la preparacion de un medicamento y metodo no-terapeuticos para el pulido de la piel y de suavizante capilar . | |
AR006867A1 (es) | Composición topica para la piel que comprende un compuesto oxa-diácido, su uso para preparar un medicamento para tratar condiciones de la piel y métodos cosméticos no terapéuticos para el pulido de la piel y para suavizar el cabello que aplican dicho compuesto. | |
AR042461A1 (es) | Analogos 2-sustituidos de quinazolin-4-il - amina. composiciones farmaceuticas | |
HK1026691A1 (en) | Substituted benzimidazoles and their use for treating retroviral infection | |
PE20001303A1 (es) | Derivados de la 4-aroilpiperidina como antagonistas del receptor ccr-3 | |
AR006720A1 (es) | Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende | |
GT199900067A (es) | Nuevas 4-fenilpiperidinas para el tratamiento dedermatosis prurìtica. | |
NO962665L (no) | Forbindelser med veksthormonfrigjörende egenskaper | |
PE20000422A1 (es) | Compuestos de amidina | |
PE20011047A1 (es) | Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas | |
PE129099A1 (es) | Derivados de la tienopirimidina y de la tienopiridina utiles como agentes anticancerigenos | |
UY23835A1 (es) | Procedimiento para la preparacion de compuesto de acilo | |
DE60112609D1 (en) | Pyrazolopyridine | |
MX9403380A (es) | Inhibidores de proteasa de vih utiles para el tratamiento de sida. | |
ES8600737A1 (es) | Procedimiento de preparar compuestos de sulfonio | |
AR031975A1 (es) | Compuestos analogos de (1r,cis)-4-(6-amino-9h-purin-9-il) -2-ciclopenteno-1-metanol, proceso para su preparacion, su uso en el tratamiento de infecciones virales, y envase que los contiene | |
DE60220525D1 (de) | Pyrazolo-pyridine für die behandlung von herpes-ansteckungen | |
DE60112330D1 (en) | Pyrazolopyridinderivate | |
SE9702564D0 (sv) | New compounds | |
ES2073246T3 (es) | Derivados de pirazina. | |
AR018700A1 (es) | Compuesto, composicion y metodo para el tratamiento de la perdida del cabello | |
DE69333413D1 (de) | 5-ht2-antagonisten in der behandlung venöser zustände |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |